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The aim of this special issue is to provide a foundation on
which further research for the development of compounds
from food as possible candidates for improving oral health
could be based. The maintenance of oral health can be
invariably achieved by manipulating the oral microbiota
toward a population of mixed species that is less likely to
induce diseases such as gingivitis or caries. Dental caries
and gingivitis are the most prevalent infectious diseases of
humans and are due to the accumulation of dental plaque
(a bacterial bioﬁlm) on the tooth surface and at the gingival
margin, respectively.
There is evidence that certain beverages and foods can
protect against caries and gingivitis. However the use of
foodstuﬀs (functional foods) as a starting point for frac-
tionation of compounds that inﬂuence the composition of
the oral microbiota to one that is beneﬁcial or at least
nonpathogenic has been the focus of intensive research [1].
An advantage of this approach is that such natural agents
are likely to be nontoxic. Furthermore, the identiﬁed active
components can be used as food supplements negating
the necessity to adhere to a particular diet as discussed
by Shmuely et al. [2]. Perhaps most important advantage
of searching for such dietary agents is that approval of
clinical trials is easier to obtain, as toxicity is usually not
an issue. Interestingly, dietary agents often lack bactericidal
activity but retain their ability to manipulate the oral
microbiota by exhibiting other important properties for
example antiadhesion or antibioﬁlm activities. Such agents
may be expected to decrease the selection pressure placed
on resistant strains and therefore reduce their emergence in
bioﬁlm communities.
The collection of manuscripts in this special issue is
mainly composed of research articles and one review article.
The latter highlights the importance of food intake with
emphasis on the eﬀect of Mediterranean diet on oral
health, discussed by G. A. Scardina and P. Messina. All
the research articles represent methodological studies by
a coherent group of investigators (Investigators from 7
academic institutions and an industrial partner representing
5 countries (University of Pavia, University of Tel Aviv,
University of Genoa, G¨ oteborg University, Academic Centre
for Dentistry Amsterdam, and the University of Verona as
wellasanindustrialpartner,Givaudan).Theconsortiumand
project were named NUTRIDENT and was a C 2.2M speciﬁc
targeted research project entitled “Towards functional foods
for oral health care-isolation, identiﬁcation and evaluation
of beverage and food components with anti-caries and/or
anti-gingivitis activities.” It was funded from within the
Framework Programme 6 (FP6)—Thematic Priority 5: Food
Quality and Safety.)
Seven plant and fungal homogenates and extracts (green
and black tea, cranberry juice, raspberries, shiitake mush-
rooms, red chicory, and beer) were subjected to a number
of microbiological assays broadly related to survival and/or
ﬁtness of speciﬁc oral bacterial species usually associated
with the development of either gingivitis or caries. This is
discussed by D. A. Spratt et al. In this study it was found that
the low-molecular-mass (LMM) fractions of shitake mush-
room and chicory homogenates had the most signiﬁcant
anticaries and antigingivitis associated activities of the seven
tested. These included inhibition of bacterial growth, adher-
ence, coaggregation, bioﬁlm formation, bioﬁlm integrity,2 Journal of Biomedicine and Biotechnology
and signal transduction. A signiﬁcant ﬁnd was that these
two homogenates also inhibited proinﬂammatory cytokine
production. Further in-depth studies by the investigators
focusing on speciﬁc bacterial activities were carried out.
Shiitake mushroom extract lowered the numbers of some
pathogenicoralbacteriawithoutaﬀectingbacteriaassociated
with oral health. This is demonstrated by L. Ciric et al.
Moreover,thecompoundsintheLMMfractionfromshiitake
mushroom inhibited dentin demineralization usually caused
by cariogenic bacteria and induced a shift in the microbiota
to that associated with oral health; this is shown by E. Zaura
et al. The LMM fraction in shiitake mushroom and chicory
homogenates also inhibited the adverse induction of genes
expression in the gingival KB cell line by gingivitis bacteria;
this is exhibited by L. Canesi et al. Eﬀorts to characterize the
eﬀectofthechicoryandmushroomextractsrevealedthatthe
extracts induced elongation of gingivitis-associated bacteria,
reminiscent to that induced by sublethal concentrations of
quinolones and β-lactam antibiotics; this is discused by C.
Signoretto et al. These in vitro ﬁndings prompted clinical
trials with the LMM shiitake mushroom fraction. In one trial
the total counts of plaque bacteria in volunteers rinsing with
mouthwash supplemented with LMM mushroom fraction
were signiﬁcantly reduced to levels similar to those in
samples of volunteers rinsing with Listerine; this is proven
by C. Signoretto et al.). In another trial it was found that
mouthwash containing the mushroom fraction reduced the
metabolicactivityofdentalplaque,suggestinganticariogenic
potentialofthefraction;thisisdemonstratedbyP.Lingstr¨ om
et al. These in vivo eﬀects are reminiscent to the outcome
of a clinical trial whereby rinsing with a cranberry fraction
caused signiﬁcant reduction in total oral bacteria including
mutans streptococci [2]. Indeed as conﬁrmation, and as
shown in this special issue, the cranberry fraction reduced
metabolic activity of preformed Streptococcus sp. bioﬁlm;
which is shown by J. Babu et al.
A detailed characterization of the plant and fungal
extracts and the fractions arising from these was carried
out by M. Daglia et al. and attempts to identify the active
component(s) were initiated. All seven plant and fungal
extracts were found to contain polyphenols; relatively high
amounts were detected in beer, cranberry, and green and
black tea by M. Daglia et al. Chicory and shiitake mushroom
homogenates and raspberry contained the highest amount
of zinc. Further studies are planned to identify the active
components in these extracts especially those in the LMM
fractions exhibiting the most favourable activity for main-
taining a community associated with oral health.
In summary, promising foods/beverages have been iden-
tiﬁed using a range of in vitro and in vivo methods. These
homogenates, or fractions of them, could be used in a num-
ber of ways to improve oral health, perhaps in mouthwashes
or chewing gum.
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